Short-acting bronchodilators for in-hospital management of acute exacerbation of COPD: Systematic Review
Conclusion: Data from the few studies available suggest that short acting beta agonists at a minimum dose via inhaler or nebuliser is sufficient for managing people admitted to hospital with AECOPD. Superfluous use could be a risk to patients with known and unknown cardiac disease.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Kopsaftis, Z., Sulaiman, N., Carson, K., Mountain, O., Phillips, P., Smith, B. Tags: Clinical Problems Source Type: research
More News: Albuterol | Chronic Obstructive Pulmonary | Clinical Trials | Hospital Management | Levalbuterol | Proair HFA | Respiratory Medicine | Study | Ventolin | Xopenex